Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/30513
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDemirkaya, A.K.-
dc.contributor.authorGündo?du, G.-
dc.contributor.authorDodurga, Yavuz-
dc.contributor.authorSeçme, M.-
dc.contributor.authorGündo?du, K.-
dc.date.accessioned2020-06-08T12:14:02Z-
dc.date.available2020-06-08T12:14:02Z-
dc.date.issued2019-
dc.identifier.issn1306-6137-
dc.identifier.urihttps://hdl.handle.net/11499/30513-
dc.identifier.urihttps://doi.org/10.17094/ataunivbd.387311-
dc.description.abstractHepatocellular carcinoma (HCC) originating from liver cells is the third leading cause of cancer-related death. Parietin is an anthraquinone, isolated from some plants such as Rheum ribes L. Cytotoxicity and genotoxicity tests have an important role in the assessment of heritable and carcinogenic risks. In this study, it was aimed to investigate the cytotoxic and genotoxic effect of parietin on HepG2 hepatocellular carcinoma cells. HepG2 cells were cultured in appropriate culture medium. Then, different concentrations of parietin (final concentrations in the well to be 25-1000 ?M) were added to the cells and they were allowed to incubate for 24-48 hours. Cell viability and genotoxic effect were determined by using XTT method and comet assay, respectively. The IC50 concentration of parietin was detected as 25 ?M at the 48 hour in HepG2 cells. According to the comet assay, there was no statistically significant increase DNA tail length, DNA tail intensity and DNA tail moment in parietin treated cell groups compared to control groups (p>0.05). In this study, it has been shown that parietin has cytotoxic at low dose, but has not genotoxic effect in HepG2 cells, and as a result parietin was found to be useful in combination with other drugs in the treatment of HepG2 cells. However, this effect of parietin should be supported by further studies. © 2019 Ataturk Universitesi. All rights reserved.en_US
dc.language.isotren_US
dc.publisherAtaturk Universitesien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectComet assayen_US
dc.subjectHepG2 cell lineen_US
dc.subjectParietinen_US
dc.subjectphyscionen_US
dc.subjectArticleen_US
dc.subjectcell cultureen_US
dc.subjectcell viabilityen_US
dc.subjectcomet assayen_US
dc.subjectcontrolled studyen_US
dc.subjectcytotoxicityen_US
dc.subjectgenotoxicityen_US
dc.subjectHep-G2 cell lineen_US
dc.subjecthumanen_US
dc.subjecthuman cellen_US
dc.subjectIC50en_US
dc.subjectliver cell carcinomaen_US
dc.subjecttail intensityen_US
dc.subjecttail length (comet assay)en_US
dc.subjecttail momenten_US
dc.subjectXTT assayen_US
dc.titleDetermination of cytotoxic and genotoxic effects of parietin in HepG2 hepatocellular carcinoma cellsen_US
dc.typeArticleen_US
dc.identifier.volume14en_US
dc.identifier.issue1en_US
dc.identifier.startpage29-
dc.identifier.startpage29en_US
dc.identifier.endpage37en_US
dc.identifier.doi10.17094/ataunivbd.387311-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-85067357050en_US
dc.identifier.trdizinid372503en_US
dc.identifier.scopusqualityQ4-
dc.ownerPamukkale University-
item.languageiso639-1tr-
item.openairetypeArticle-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.03. Basic Medical Sciences-
crisitem.author.dept14.03. Basic Medical Sciences-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
Files in This Item:
File SizeFormat 
10.17094-ataunivbd.387311-703997.pdf494.38 kBAdobe PDFView/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

2
checked on Jun 29, 2024

Page view(s)

84
checked on May 27, 2024

Download(s)

22
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.